Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The metabolism of low-density lipoprotein (LDL) was studied in six insulin-dependent (type I) diabetic patients during a 7-wk period of conventional and intensive therapy with insulin. Plasma glucose and HbA(1c) were normalized, demonstrating the effectiveness of our intensive treatment program. Plasma lipoprotein profiles and LDL apolipoprotein B kinetic parameters were estimated during conventional and then during intensive therapy for each patient. Intensive therapy resulted in a significant reduction of plasma and LDL cholesterol and an increase in high-density lipoprotein (HDL) cholesterol. The lower LDL levels resulted from a decreased production of lipoprotein rather than an increased fractional catabolic rate. These results are consistent with our previous observations of very-low-density lipoprotein (VLDL) metabolism during intensive therapy. VLDL production is significantly reduced; thus, a decreased production of LDL supports the contention that intensive therapy with insulin in normolipemic type I diabetic patients reduces the production of lipoproteins containing apolipoprotein B rather than increasing the clearance, and therapy also increases HDL cholesterol. Both of these effects may be beneficial in reducing the risk for coronary heart disease in type I diabetes.

Original languageEnglish (US)
Pages (from-to)393-397
Number of pages5
JournalDiabetes
Volume37
Issue number4
StatePublished - 1988

Fingerprint

Apolipoproteins B
Type 1 Diabetes Mellitus
LDL Lipoproteins
Lipoproteins
VLDL Lipoproteins
Insulin
HDL Cholesterol
Therapeutics
LDL Cholesterol
Coronary Disease
Glucose

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes. / Rosenstock, J.; Vega, Gloria L; Raskin, Philip.

In: Diabetes, Vol. 37, No. 4, 1988, p. 393-397.

Research output: Contribution to journalArticle

@article{8e46d6b9921147b082179bc2ac2d4147,
title = "Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes",
abstract = "The metabolism of low-density lipoprotein (LDL) was studied in six insulin-dependent (type I) diabetic patients during a 7-wk period of conventional and intensive therapy with insulin. Plasma glucose and HbA(1c) were normalized, demonstrating the effectiveness of our intensive treatment program. Plasma lipoprotein profiles and LDL apolipoprotein B kinetic parameters were estimated during conventional and then during intensive therapy for each patient. Intensive therapy resulted in a significant reduction of plasma and LDL cholesterol and an increase in high-density lipoprotein (HDL) cholesterol. The lower LDL levels resulted from a decreased production of lipoprotein rather than an increased fractional catabolic rate. These results are consistent with our previous observations of very-low-density lipoprotein (VLDL) metabolism during intensive therapy. VLDL production is significantly reduced; thus, a decreased production of LDL supports the contention that intensive therapy with insulin in normolipemic type I diabetic patients reduces the production of lipoproteins containing apolipoprotein B rather than increasing the clearance, and therapy also increases HDL cholesterol. Both of these effects may be beneficial in reducing the risk for coronary heart disease in type I diabetes.",
author = "J. Rosenstock and Vega, {Gloria L} and Philip Raskin",
year = "1988",
language = "English (US)",
volume = "37",
pages = "393--397",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes

AU - Rosenstock, J.

AU - Vega, Gloria L

AU - Raskin, Philip

PY - 1988

Y1 - 1988

N2 - The metabolism of low-density lipoprotein (LDL) was studied in six insulin-dependent (type I) diabetic patients during a 7-wk period of conventional and intensive therapy with insulin. Plasma glucose and HbA(1c) were normalized, demonstrating the effectiveness of our intensive treatment program. Plasma lipoprotein profiles and LDL apolipoprotein B kinetic parameters were estimated during conventional and then during intensive therapy for each patient. Intensive therapy resulted in a significant reduction of plasma and LDL cholesterol and an increase in high-density lipoprotein (HDL) cholesterol. The lower LDL levels resulted from a decreased production of lipoprotein rather than an increased fractional catabolic rate. These results are consistent with our previous observations of very-low-density lipoprotein (VLDL) metabolism during intensive therapy. VLDL production is significantly reduced; thus, a decreased production of LDL supports the contention that intensive therapy with insulin in normolipemic type I diabetic patients reduces the production of lipoproteins containing apolipoprotein B rather than increasing the clearance, and therapy also increases HDL cholesterol. Both of these effects may be beneficial in reducing the risk for coronary heart disease in type I diabetes.

AB - The metabolism of low-density lipoprotein (LDL) was studied in six insulin-dependent (type I) diabetic patients during a 7-wk period of conventional and intensive therapy with insulin. Plasma glucose and HbA(1c) were normalized, demonstrating the effectiveness of our intensive treatment program. Plasma lipoprotein profiles and LDL apolipoprotein B kinetic parameters were estimated during conventional and then during intensive therapy for each patient. Intensive therapy resulted in a significant reduction of plasma and LDL cholesterol and an increase in high-density lipoprotein (HDL) cholesterol. The lower LDL levels resulted from a decreased production of lipoprotein rather than an increased fractional catabolic rate. These results are consistent with our previous observations of very-low-density lipoprotein (VLDL) metabolism during intensive therapy. VLDL production is significantly reduced; thus, a decreased production of LDL supports the contention that intensive therapy with insulin in normolipemic type I diabetic patients reduces the production of lipoproteins containing apolipoprotein B rather than increasing the clearance, and therapy also increases HDL cholesterol. Both of these effects may be beneficial in reducing the risk for coronary heart disease in type I diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0023904350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023904350&partnerID=8YFLogxK

M3 - Article

C2 - 3288528

AN - SCOPUS:0023904350

VL - 37

SP - 393

EP - 397

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -